Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	May 13, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,438	25,891	16,074	8,451	2,820	3,477
Market Cap Growth	-35.17%	61.07%	90.20%	199.72%	-18.91%	3.61%
Enterprise Value	9,947	23,747	15,869	8,249	2,326	2,919
Last Close Price	78.60	182.21	120.73	67.04	23.53	29.02
PE Ratio	24.24	35.62	-	-	-	-
PS Ratio	12.78	23.40	81.32	289.08	97.71	41.36
PB Ratio	4.29	9.39	22.29	18.25	5.23	4.23
P/TBV Ratio	4.34	9.52	23.46	19.80	5.59	4.45
P/FCF Ratio	16.70	38.79	-	-	-	-
P/OCF Ratio	16.66	38.74	-	-	-	-
EV/Sales Ratio	10.22	21.47	80.28	282.15	80.61	34.72
EV/EBITDA Ratio	18.39	34.00	-	-	-	-
EV/EBIT Ratio	18.74	34.25	-	-	-	-
EV/FCF Ratio	13.35	35.58	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.07	0.02	-	-	-	-
Debt / FCF Ratio	0.05	0.02	-	-	-	-
Asset Turnover	0.43	0.58	0.31	0.05	0.04	0.11
Quick Ratio	17.71	12.93	11.63	10.05	9.05	15.60
Current Ratio	17.75	12.96	13.07	10.57	10.79	16.71
Return on Equity (ROE)	21.92%	41.81%	-6.76%	-49.43%	-41.47%	-23.73%
Return on Assets (ROA)	14.66%	22.64%	-8.54%	-29.36%	-27.20%	-15.98%
Return on Capital (ROIC)	15.72%	24.62%	-8.99%	-30.89%	-28.46%	-16.84%
Return on Capital Employed (ROCE)	17.60%	24.50%	-	-	-	-
Earnings Yield	3.64%	2.81%	-0.25%	-2.93%	-10.00%	-5.11%
FCF Yield	5.99%	2.58%	-1.32%	-2.19%	-11.20%	-6.78%
Dividend Yield	1.27%	0.55%	-	-	-	-
Buyback Yield / Dilution	-7.81%	-7.29%	-6.65%	-1.87%	-5.35%	-4.89%
Total Shareholder Return	-6.54%	-6.74%	-6.65%	-1.87%	-5.35%	-4.89%

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.